prostate cancer patients. C61 Malignant neoplasm of prostate
Conditions
Interventions
Intervention 1: Intervention group :
The applied progressive muscle relaxation training (APMRT) therapy that is provided to the intervention group included three 50-minute group education sessions
Placebo
Intervention group :
The applied progressive muscle relaxation training (APMRT) therapy that is provided to the intervention group included three 50-minute group education sessions over 6 weeks.
Control group:
The control in a quasi-experimental trial should not give any intervention. However, it was unethical to withhold information which could benefit the subjects. Therefore the control gr
Sponsors
University of Malaya
Eligibility
Sex/Gender
Male
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria i. Patients diagnosed with prostate cancer confirmed by the histology of prostate gland cell. ii. Patients with 50 years old and above. Exclusion criteria i. Patients who have been diagnosed any cancer other than prostate cancer ii. Patients who have been diagnosed with any psychiatric diagnosis iii. Patients who are currently use of psychiatric medication iv. Patients who are having prior training or current use of relaxation therapy v. Patients who have presence of physical limitations for learning Progrressive Muscle Relaxation Training (eg: bed-bound) vi. Patients who did not understand Bahasa Malaysia and English vii. Patients with no contact number
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact of Applied progressive muscle relaxation training to the level of depression, anxietyand stress. Timepoint: after 6 months from the first intervention. Method of measurement: Using DASS scale score.;The impact of the Appplied Progressive muscle relaxation training to the level of quality of life. Timepoint: after 6 months fro mthe first intervention. Method of measurement: SF-36 Quality of life questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the pattern and characteristics in the study population. Timepoint: at the baseline data collected. Method of measurement: the socio-demographic, past medical and surgical illness, urological sign and symptoms and the status of the prostate cancer.;To assess the quality of life among the study population. Timepoint: After the baseline data collected. Method of measurement: SF-36 quality of life questionnaire.;To determine prevalence of depression, anxiety and stress among prostate cancer patient. Timepoint: at the baseline data collected. Method of measurement: by using DASS scale score.;To describe the differences of the quality of life between the depression, anxiety and stress status in the study population. Timepoint: At the baseline data collected. Method of measurement: DASS scale score and SF-36 Quality of life questionnnaire.;To determine the correlation between depression, anxiety and stress level among study population. Timepoint: At the baseline data collected. Method of measurement: DASS sccale score and SF-36 Quality of life Questionnaires.;To compare the quality of life of the metastases status among prostate cancer patients. Timepoint: At the baseline data collected. Method of measurement: SF-36 quality of life questionnaire. | — |
Countries
Malaysia
Contacts
Public ContactMohamad Rodi bin Isa
University of Malaya
Outcome results
None listed